Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Invested Capital (2021 - 2026)

Nutex Health (NUTX) has disclosed Return on Invested Capital for 7 consecutive years, with 0.38% as the latest value for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 37.0% year-over-year to 0.38%; the TTM value through Mar 2026 reached 0.38%, down 37.0%, while the annual FY2025 figure was 0.48%, 34.0% down from the prior year.
  • Return on Invested Capital hit 0.38% in Q1 2026 for Nutex Health, up from 0.37% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.82% in Q4 2024 and bottomed at 3.16% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 0.37%, with a median of 0.1% recorded in 2023.
  • Year-over-year, Return on Invested Capital crashed -358bps in 2023 and then surged 294bps in 2024.
  • Nutex Health's Return on Invested Capital stood at 2.65% in 2022, then skyrocketed by 89bps to 0.3% in 2023, then surged by 375bps to 0.82% in 2024, then crashed by -55bps to 0.37% in 2025, then grew by 3bps to 0.38% in 2026.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.38%, 0.37%, and 0.74% for Q1 2026, Q4 2025, and Q3 2025 respectively.